Adoptive Immunotherapy in Chimeras with Donor Lymphocytes

Publisher： Karger

E-ISSN： 1421-9662|110|2-3|110-120

ISSN： 0001-5792

Source： Acta Haematologica, Vol.110, Iss.2-3, 2003-10, pp. : 110-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy

By  

Transfusion Medicine and Hemotherapy, Vol. 44, Iss. 5, 2017-09 ,pp. : 337-350

Karger

Access to resources Recommend Favorite

Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 3, 2011-05 ,pp. : 173-182

Karger

Access to resources Recommend Favorite

Clinical Applications of Adoptive Natural Killer Cell Immunotherapy for Cancer: Current Status and Future Prospects

By  

Oncology Research and Treatment, Vol. 33, Iss. 7, 2010-06 ,pp. : 389-395

Karger

Access to resources Recommend Favorite

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 827-832

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alternative Concepts of Suicide Gene Therapy for Graft-versus-Host Disease after Adoptive Immunotherapy

By  

Acta Haematologica, Vol. 110, Iss. 2-3, 2003-10 ,pp. : 132-138

Karger

Access to resources Recommend Favorite